Research output per year
Research output per year
Personal profile
Research Biography
Following a post-doctoral period where I studied lysosomes using the then novel technique of Proteomics, I moved to Flinders and shortly after, established the Flinders Proteomics facility in 2002. Following further post-doctoral research, I was awarded the Sir Mark Oliphant fellowship using Proteomics to study neurodegeneration. I currently manage the Proteomics facility and a small research team which uses Proteomics to study allergy and antibodies.
Research Interests
- Proteomics to study neurodegeneration
- Proteomics to study allergy and antibodies
Research Expertise
Proteomics
Completed Supervisions
Principal Supervisions:
- Parkinson's disease, Multiple System Atrophy, Mass Spectrometry, VAMP2 (1)
- Proteomics, Purification, Lewy body, Parkinson's disease, Multiple system atrophy, Glial cytoplasmic inclusion, mass spectrometry (1)
Associate Supervisions:
- Claudication, Calpain, Muscle, ELISA (1)
- ELISA, Motor neurone disease (1)
- Mass spectrometry, Biotechnology, Saponin (1)
- Mitochondria, mutation, PCR (1)
- Proteomics, Actinobacteria, Mass Spectrometry, Biocontrol, Agriculture (1)
Supervision
- Registered
Research Areas
- Molecular biosciences
Supervisory Interests
- Proteomics
- Neuroscience
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 6 Clean Water and Sanitation -
SDG 14 Life Below Water
Fingerprint
Dive into the research topics where Tim Chataway is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Wang, J. J., Schönborn, L., Warkentin, T. E., Müller, L., Thiele, T., Ulm, L., Völker, U., Ameling, S., Franzenburg, S., Kaderali, L., Tzvetkova, A., Colella, A., Chataway, T., Tan, C. W., Armour, B., Troelnikov, A., Rutten, L., McCluskey, J., Zahn, R. & Gordon, T. & 1 others, , 12 Feb 2026, In: The New England journal of medicine. 394, 7, p. 669-683 15 p.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Early differential protein expression in blood and bronchoalveolar fluid among ARDS phenotypes
Wildi, K., Bihari, S., Bersten, A., Dixon, D. L., Paul, E., McGuinness, S., Hodgson, C., Nichol, A., Chataway, T., Colella, A. D., Gebhard, C. E., Chegeni, N., Matigian, N., LiBassi, G., Passmore, M., Bouquet, M., Ritchie, A., Suen, J., Fraser, J. & PHARLAP Study Investigators, 22 Apr 2026, In: Scientific Reports. 16, 1, 14 p., 18748.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Structural Mass-Spectrometric Description of Immune Complexes in Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Troelnikov, A., Ellis, S., Collela, A., Schönborn, L., Greinacher, A., Gordon, T. P., Pukala, T. L., Chataway, T. & Wang, J. J., 8 Apr 2026, In: Journal of the American Chemical Society. 148, 13, p. 13610-13618 9 p.Research output: Contribution to journal › Article › peer-review
-
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer
Fang, D. M., Shrestha, R. K., German, B., Rahman, R., Townley, S. L., Xie, J., Hanson, A. R., Iggo, R., Nassar, Z. D., Helm, M., Marri, S., Colella, A. D., Best, G., Centenera, M. M., Tilley, W. D., Chataway, T. K., Ellis, L., Butler, L. M. & Selth, L. A., 2 Jun 2026, In: Cell death & disease. 17, 1, 13 p., 687.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Shared molecular profiles of anti-PL12 autoantibodies in anti-synthetase syndrome.
Ali, S. B., Troelnikov, A., Amour, B., Hender, L., Beroukas, D., Chataway, T., Limaye, V., Gordon, T. P. & Wang, J. J., 1 Dec 2025, In: Rheumatology. 64, 12, p. 6398-6403 6 p., keaf357.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)28 Downloads (Pure)
-
Antibody fingerprinting to solve an unsolved crime: Is type 1 diabetes (T1D) caused by antibody responses to a common childhood viral infection?
Jessup, C. (Chief Investigator (Project Lead)), Wang, J. J. (Associate Investigator), Mannering, S. (Associate Investigator), Penno, M. (Associate Investigator), Tan, F. (Associate Investigator), Hatchard, L. (Associate Investigator), Chataway, T. (Associate Investigator), Walker, G. (Associate Investigator), Wentworth, J. M. (Associate Investigator) & Woodman, R. (Associate Investigator)
27/02/26 → 31/12/27
Project: Research
-
Neuropsychological outcomes after elective treatment of anterior communicating artery aneurysms and the potential prognostic role of radiomics and proteomics
Van Der Veken, J. (Chief Investigator (Project Lead)), Stoodley, M. (Chief Investigator), Kneebone, A. (Associate Investigator), Oxenham, V. (Associate Investigator), Harding, M. (Associate Investigator), Paterson, F. (Associate Investigator), to, M.-S. (Associate Investigator), Chryssidis, S. (Associate Investigator), Chataway, T. (Associate Investigator), Dwyer, A. (Associate Investigator) & Tomatis, V. (Associate Investigator)
19/02/26 → 15/01/29
Project: Research
-
Molecular analysis of pathogenic rheumatoid factor repertoires in patients with primary Sjögren’s syndrome
Wang, J. J. (Chief Investigator (Project Lead)), Thurlings, R. (Chief Investigator), Chataway, T. (Associate Investigator) & Gordon, T. (Chief Investigator)
31/01/22 → 31/12/22
Project: Research
File